Subcutaneous pembrolizumab: a meaningful advance in cancer treatment delivery
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Nonmelanoma Skin Cancer Studies
Publication details
- Journal / source
- Journal of Thoracic Disease
- Publisher
- AME Publishing Company
- Volume
- 18
- Issue
- 2
- Pages
- 53–53
- Publication date
- 1 February 2026
- Language
- EN